EGF Ointment for Erlotinib Skin Lesion
NCT01593995
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
52
Enrollment
OTHER
Sponsor class
Conditions
Non-small Cell Lung Cancer
Pancreatic Cancer
Interventions
DRUG:
Epidermal growth factor (EGF) ointment
Sponsor
Dong-A University Hospital